Weekly Digest – March 2026 Weekly Digest – March 2026 17 March 2026: Alphamab Oncology announces the first patient dosed in a Phase 1 clinical study of PD-L1/VEGFR2 bispecific ADC JSKN027 Alphamab Oncology continues to expand its ADC pipeline, announcing […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id